Kulek Publications

    1. Kulek AR, Undyala VVR, Anzell AR, Raghunayakula S, MacMillan-Crow LA, Sanderson TH, Przyklenk K. Does Disruption of Optic Atrophy-1 (OPA1) Contribute to Cell Death in HL-1 Cardiomyocytes Subjected to Lethal Ischemia-Reperfusion Injury? Cells. 2022 Sep 30;11(19):3083. doi: 10.3390/cells11193083.PMID: 36231044
    2. Kulek AR, Anzell A, Wider JM, Sanderson TH, Przyklenk K. Mitochondrial Quality Control: Role in Cardiac Models of Lethal Ischemia-Reperfusion Injury. Cells 2020, 9, 214; DOI: 10.3390/cells9010214
    3. Iraji A, Chen H, Wiseman N, Zhang T, Welch R, O'Neil B., Kulek A, Ayaz SI Wang X. Zuk C, Haacke EM, Liu T, Kou Z. Connectome-scale assessment of structural and functional connectiv-ity in mild traumatic brain injury at the acute stage. Neuroimage Clin (2016) 12:100-115.
    4. Iraji A, Benson RR, Welch RD, O'Neil BJ, Woodard JL, Ayaz SI, Kulek A, Medado, Soltanian-Zadeh H, Liu T, Haacke EM, Kuo Z. Resting State Functional Connectivity in Mild Traumatic Brain Injury at the Acute Stage. J Neurotrauma 2015;32(14): 1031-1045
    5. Ayaz SI, Thomas C, Kulek A. Tolomello R, Mika V, Robinson D, Medado P, Pearson C, Prichep L, O'Neil BJ. Comparison of Quantitative EEG to current clinical decision rules for Head CT use in acute mild traumatic brain injury in the ED. American Journal of Emergency Medicine 2015, 33(4):493-6.
    6. Guo J, Chen XF, Liu J, Lin HY, Han HW, Liu HC, Huang SC, Shahla BK, Kulek A, Qi JL, Wang XM, Ling LJ, Yang YH. Novel Shikonin Derivatives Targeting Tubulin as Anticancer Agents. Chemical Biology & Drug Design 2014; 84(5):603-15.
    7. Kou Z, Gattu R, Kobeissy F, Welch RD, O'Neil BJ, Woodard JL, Ayaz SI, Kulek A, Kas-Shamoun R, Mika V, Zuk C, Tomasello F, Mondello S. Combining Biochemical and Imaging Markers to Improve Diagnosis and Characterization of Mild Traumatic Brain Injury in the Acute Setting: Results from a Pilot Study. PLoS ONE 2013; 8(11): e80296